LYV:NYSELive Nation Entertainment, Inc. Analysis
Data as of 2026-03-10 - not real-time
$165.53
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Live Nation’s price is trading comfortably above both its 20‑day and 50‑day moving averages, and the MACD histogram remains in bullish territory, suggesting short‑term momentum is intact. The RSI sits in the upper‑mid range, indicating strength without clear overbought pressure, while volume has been stable, supporting the price advance. However, the stock’s forward price‑to‑earnings multiple towers far above the industry average and the DCF‑derived fair value still trails the current market price, flagging a potentially stretched valuation. Volatility over the past month is elevated and beta is modest, pointing to a stock that can swing sharply but is less correlated with broader market moves.
On the fundamental side, revenue is growing at double‑digit rates and the company continues to benefit from robust concert demand and expanding sponsorship bookings. Margins remain thin and the firm carries a high debt load relative to equity, with no dividend to offset the valuation concerns. The most material catalyst this week is the DOJ settlement, which eases immediate antitrust pressure but does not eliminate the underlying regulatory risk. Investors should weigh the bullish technical setup and growth narrative against the lofty valuation, heavy leverage, and lingering legal exposure.
On the fundamental side, revenue is growing at double‑digit rates and the company continues to benefit from robust concert demand and expanding sponsorship bookings. Margins remain thin and the firm carries a high debt load relative to equity, with no dividend to offset the valuation concerns. The most material catalyst this week is the DOJ settlement, which eases immediate antitrust pressure but does not eliminate the underlying regulatory risk. Investors should weigh the bullish technical setup and growth narrative against the lofty valuation, heavy leverage, and lingering legal exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent DOJ settlement reduces immediate legal uncertainty
- Bullish technical indicators support current price levels
- Valuation remains stretched relative to earnings outlook
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained revenue growth and strong concert demand
- Potential for improved margins as sponsorships expand
- Resolution of antitrust issues could unlock upside
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Long‑term structural shift toward live experiences
- High leverage and lack of dividend limit downside protection
- Valuation premium may persist without clear earnings acceleration
Key Metrics & Analysis
Financial Health
Revenue Growth11.10%
Profit Margin1.97%
P/E Ratio73.0
ROE36.70%
ROA3.89%
Debt/Equity572.03
P/B Ratio142.9
Op. Cash Flow$1.4B
Free Cash Flow$1.1B
Industry P/E18.2
Technical Analysis
TrendBullish
RSI63.5
Support$147.72
Resistance$168.54
MA 20$158.42
MA 50$150.12
MA 200$149.90
MACDBullish
VolumeStable
Fear & Greed Index76.91
Valuation
Fair Value$90.68
Target Price$182.59
Upside/Downside10.31%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.89
Volatility34.09%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.